home / stock / nvzmy / nvzmy news


NVZMY News and Press, Novozymes A/S ADR From 05/01/24

Stock Information

Company Name: Novozymes A/S ADR
Stock Symbol: NVZMY
Market: OTC
Website: novonesis.com/en/

Menu

NVZMY NVZMY Quote NVZMY Short NVZMY News NVZMY Articles NVZMY Message Board
Get NVZMY Alerts

News, Short Squeeze, Breakout and More Instantly...

NVZMY - Expected US Company Earnings on Wednesday, May 1st, 2024

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

NVZMY - Expected US Company Earnings on Wednesday, April 24th, 2024

Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...

NVZMY - Expected earnings - Novonesis AS ADR

Novonesis AS ADR (NVZMY) is expected to report for Q1 2024

NVZMY - DSM-Firmenich: Not Seeing Much Benefit From The Merger Yet

2024-03-22 04:03:34 ET Summary DSM-Firmenich reports underwhelming results in the challenging vitamin market and plans to separate Animal Nutrition & Health business in 2025. The company continues to invest heavily in R&D, with recent breakthroughs including the creation o...

NVZMY - Novonesis: A New Beginning For Novozymes And Christian Hansen

2024-03-06 01:43:24 ET Summary Novozymes reported its last annual results for fiscal 2023 with revenue growing, but bottom line declining. Novonesis is the new company generated by the merger between Novozymes and Christian Hansen. The stock is trading above intrinsic value on...

NVZMY - Novo Nordisk's parent eyes $7B annual investments by 2030: FT

2024-02-12 08:41:44 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Booming weight-loss drug market to lift “pick-and-shovel...

NVZMY - International Wide-Moat Stocks On Sale - The February 2024 Heat Map

2024-02-09 02:51:35 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

NVZMY - Novozymes A/S (NVZMF) Q4 2023 Earnings Call Transcript

2024-02-01 15:26:03 ET Novozymes A/S (NVZMF) Q4 2023 Earnings Conference Call February 01, 2024 3:00 AM ET Company Participants Tobias Björklund – Head-Investor Relations Ester Baiget – Chief Executive Officer Rainer Lehmann – Chief Fina...

NVZMY - Expected US Company Earnings on Thursday, February 1st, 2024

IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...

NVZMY - Expected US Company Earnings on Thursday, January 25th, 2024

Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...

Previous 10 Next 10